Soluble beta-1,3/1,6-glucan

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSoluble beta-1,3/1,6-glucan
Drug Alias NameSBGSoluble beta-glucanWoulgan
ClassificationSmall molecules
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiotec Pharmacon As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotec Pharmacon As
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A